Acquired resistance to BRAF-inhibitors restores melanoma tumor immune suppression
Ontology highlight
ABSTRACT: The acquisition of resistance to BRAF-inhibitors results in MAPK-driven, CCL2-mediated repopulation of intratumoral myeloid-derived suppressor cells (MDSCs) in a mouse model of melanoma, and the depletion of MDSCs allows for effective immunotherapy against drug-resistant tumors.
ORGANISM(S): Mus musculus
PROVIDER: GSE79206 | GEO | 2017/03/01
SECONDARY ACCESSION(S): PRJNA315156
REPOSITORIES: GEO
ACCESS DATA